Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eppur si muove: the dynamic brain pericyte. | Fluids Barriers CNS | 2025 | 41029706 | PubTator, text mining | PubMed |
| Mechanotransduction in Shaping Immunity: Pathways, Crosstalk, and Pathophysiological Relevance. | Adv Sci (Weinh) | 2025 | 41020578 | PubTator, text mining | PubMed |
| Recent Advances in Therapeutics for Severe Fever with Thrombocytopenia Syndrome Virus. | Viruses | 2025 | 41012602 | PubTator, text mining | PubMed |
| Proteomic Screening for Cellular Targets of the Duck Enteritis Virus Protein VP26 Reveals That the Host Actin-Myosin II Network Regulates the Proliferation of the Virus. | Int J Mol Sci | 2025 | 41009665 | PubTator, text mining | PubMed |
| The F1148 hydrophobic lock: A critical determinant of SARS-CoV-2 spike protein-mediated membrane fusion via the 3H/CH cavity. | PLoS Pathog | 2025 | 40972091 | PubTator, text mining | PubMed |
| Retraction Note: TFPI-2 suppresses breast cancer cell proliferation and invasion through regulation of ERK signaling and interaction with actinin-4 and myosin-9. | Sci Rep | 2025 | 40962880 | PubTator, text mining | PubMed |
| Single-vessel transcriptome map pathological landscapes and reveal NR2F2-mediated smooth muscle cell phenotype acquisition in capillary malformations. | bioRxiv | 2025 | 40950147 | PubTator, text mining | PubMed |
| Clinical Utility of a Targeted Next-Generation Sequencing Panel for Inherited Platelet Disorders in Children. | Diagnostics (Basel) | 2025 | 40941697 | PubTator, text mining | PubMed |
| Myosin heavy chain 9 is a critical host factor for Japanese encephalitis virus entry and replication in U251 cells. | Vet Microbiol | 2025 | 40939426 | PubTator, text mining | PubMed |
| [Case Analysis of MYH9 Related Disease with Non-Hodgkin Lymphoma Caused by Rare Mutations]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2025 | 40936143 | PubTator, text mining | PubMed |
| A novel variant of MYH9 mutation associated macro-thrombocytopenia: A case series. | Transfus Apher Sci | 2025 | 40934793 | PubTator, text mining | PubMed |
| Construction of a prognostic risk model for acute myeloid leukemia based on exosomal genes and analysis of immune microenvironment characteristics. | Sci Rep | 2025 | 40890357 | PubTator, text mining | PubMed |
| Retraction Note: Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis. | Sci Rep | 2025 | 40890223 | PubTator, text mining | PubMed |
| Successful kidney transplantation using eltrombopag in a patient with MYH9-related disease. | CEN Case Rep | 2025 | 40889065 | PubTator, text mining | PubMed |
| CD99-mediated immunological synapse formation potentiates CAR-T cell function. | Nat Commun | 2025 | 40866332 | PubTator, text mining | PubMed |
| The relationship between immune cell infiltration and necroptosis gene expression in sepsis: an analysis using single-cell transcriptomic data. | Front Cell Infect Microbiol | 2025 | 40861493 | PubTator, text mining | PubMed |
| Current status of severe fever with thrombocytopenia syndrome in China (Review). | Int J Mol Med | 2025 | 40849814 | PubTator, text mining | PubMed |
| Maspin/SerpinB5 is a cytoskeleton-binding protein that regulates epithelial cell shape. | Commun Biol | 2025 | 40846899 | PubTator, text mining | PubMed |
| Target discovery-directed pharmacological mechanism elucidation of bioactive natural products. | Med Rev (2021) | 2025 | 40838108 | PubTator, text mining | PubMed |
| Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | 40830968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=7